Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.
Ethics Forum: Understanding the Challenges in Rheumatology Today
Understand the challenges in rheumatology today
REF President: Annual Giving Is the Foundation of Our Core Awards
Annual giving is a fundraising component of the ACR Research and Education Foundation’s (REF’s) comprehensive development plan—the other main sources being the Industry Roundtable and planned giving, otherwise known as The Legacy Society. What has always struck me about annual giving is the munificence of our donors. When it comes to annual giving, most donors are ACR members whose spirit of generosity makes it possible for the REF to fulfill its mission of advancing research and training to improve the health of people with rheumatic diseases.
Recent Study Improves Understanding of Preclinical Rheumatoid Arthritis
A study recently published in Arthritis Care & Research (AC&R) reveals a novel approach for the study of preclinical rheumatoid arthritis (RA). The investigators conducting the study sought to determine if these RA-related biomarkers could also be found in healthy subjects in order to investigate relationships between genetic and environmental factors and the presence of these biomarkers. Their goal is to study how these biomarkers evolve.
Cardiovascular Disease Risk High in RA Patients
High incidence of metabolic disease and concurrent inflammation increases risk
Cobra Therapy for Rheumatoid Arthritis
Initial high-dose therapy may help patients seeking relief
Within Our Reach–Funded Study Finds Increased Depression Risk Among Some RA Patients
A study recently published in Arthritis & Rheumatism found that a cohort of patients from multiethnic backgrounds who all had rheumatoid arthritis (RA) had nearly double the rate of depressive symptoms compared with middle-class white patients with RA.1 The study also examined predictors of depression, and concluded that physical disability—not acute disease activity—is the principal predictor of depression in patients with RA.
Bridge the Gap Between Goal and Attainment
Use motivational interviewing to facilitate behavior change for your clients
Couples Coping with Chronic Pain
Spouses provide help to their partners, but also need help themselves
RA Therapy Can Increase Risk for Lung Disease
Vigilant screening for NTM lung disease and latent tuberculosis needed
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 45
- Next Page »